Table 1 Patient characteristics for antibiotic prescription and outcomes among outpatients or inpatients.
From: Prevalence and characteristics of antibiotic prescription for acute COVID-19 patients in Japan
Characteristic | Antibiotics prescribed (n = 7741) | Not prescribed (n = 65,786) | Adjusted odds ratio (95% CI)* for antibiotic prescription |
|---|---|---|---|
A: Outpatients with acute COVID-19 between Jan 2020 and Nov 2021 in Japan (N = 73,527) | |||
Older patients, n (%) | 4271 (55.17%) | 9079 (13.80%) | 4.66 (4.41, 4.93) |
Male, n (%) | 4308 (55.65%) | 35,667 (54.22%) | 1.02 (0.97, 1.08) |
Charlson index, mean (SD) | 3.09 (3.51) | 0.71 (1.82) | 1.22 (1.21, 1.23) *** |
Characteristic/outcome | Antibiotics prescribed (n = 10,809) | Not prescribed (n = 56,103) | Adjusted odds ratio (95% CI)** for antibiotic prescription |
|---|---|---|---|
B: Inpatients with acute COVID-19 between Jan 2020 and Nov 2021 in Japan (N = 66,912) | |||
Older patients, n (%) | 5885 (54.45%) | 16,375 (29.19%) | 2.10 (2.01, 2.21) |
Male, n (%) | 6690 (61.89%) | 31,758 (56.61%) | 1.12 (1.07, 1.18) |
Charlson index, mean (SD) | 3.59 (3.11) | 2.34 (2.81) | 1.06 (1.05, 1.07)*** |
Oxygen therapy, n (%) | 6596 (61.02) | 15,073 (26.87) | 3.44 (3.28, 3.60) |
Invasive mechanical ventilation, n (%) | 1674 (15.49) | 564 (1.01) | 15.09 (13.60, 16.74) |
In-hospital mortality, n (%) | 1332/10,809 (12.33%) | 1058/56,103 (1.89%) | N/A |
Hospital stay, mean days (SD) | 17.42 (0.17) | 10.79 (0.04) | N/A |
